Market Overview

Charles River Labs Closes Purchase of Majority Ownership of Vital River

Share:
Related CRL
Charles River Laboratories, AstraZeneca Renew Strategic Partnership Agreement
Benzinga's Top Downgrades

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed its acquisition of a 75% ownership of Vital River, the premier commercial provider of research models and related services in China, and a licensee of Charles River for the last ten years.

Posted-In: News M&A

 

Related Articles (CRL)

Get Benzinga's Newsletters